Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6433645 | 0.85 | ALOX5 (0.46) | ALDH1A1TAS2R14ALOX5MAPTHSD17B10 | |
| SCHEMBL9083176 | 0.85 | ALDH1A1 (0.40) | ALDH1A1TAS2R14ALOX5MAPTTSHR | |
| SCHEMBL23124452 | 0.81 | ALDH1A1 (0.44) | ALDH1A1MAPTTSHRTDP1L3MBTL1 | |
| SCHEMBL9194241 | 0.81 | HSD17B10 (0.51) | ALDH1A1TAS2R14MAPTTSHRHSD17B10 | |
| SCHEMBL10526899 | 0.79 | TSHR (0.46) | ALDH1A1MAPTTSHRHSD17B10HPGD | |
| SCHEMBL17038874 | 0.76 | ALDH1A1 (0.45) | ALDH1A1ALOX5MAPTHSD17B10EPHX2 | |
| SCHEMBL3324604 | 0.74 | POLB (0.55) | ALDH1A1MAPTTSHREPHX2MEN1 | |
| SCHEMBL8445238 | 0.72 | POLB (0.40) | ALDH1A1ALOX5MAPTHSD17B10EPHX2 | |
| SCHEMBL25097667 | 0.72 | ALDH1A1 (0.39) | ALDH1A1ALOX5MAPTHSD17B10TDP1 | |
| SCHEMBL17035939 | 0.72 | RIPK1 (0.39) | ALDH1A1ALOX5MAPTTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4293076-B1 | SELF-HEALING RUBBER COMPRISING A POLY(GLYCEROLMONOMETHACRYLATE) BORONIC ESTER COMPLEX | BRIDGESTONE CORP (JP) | 2025-04-02 | — | — | EP | claimed |
| EP-3587859-B1 | TRANSMISSION BELT | MITSUBOSHI BELTING LTD (JP) | 2024-12-18 | — | — | EP | claimed |
| EP-3822510-B1 | FRICTION TRANSMISSION BELT | BANDO CHEMICAL IND (JP) | 2022-09-07 | — | — | EP | claimed |
| EP-4363466-B1 | PROCESSING OPTIMIZED REACTIVE POLYMER COMPOSITION | CLARIANT INT LTD (CH) | 2025-04-09 | — | — | EP | disclosed |
| EP-4363466-A1 | PROCESSING-OPTIMIZED, REACTIVE POLYMER COMPOSITION | Clariant International Ltd (CH) | 2024-05-08 | — | — | EP | disclosed |
| US-20230000773-A1 | NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ARES CAPITAL CORPORATION, AS AGENT | 2023-01-05 | — | — | US | disclosed |
| WO-2023274706-A1 | PROCESSING-OPTIMIZED, REACTIVE POLYMER COMPOSITION | CLARIANT INTERNATIONAL LTD (CH) | 2023-01-05 | — | — | WO | disclosed |
| US-20230000773-A1 | NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ARES CAPITAL CORPORATION, AS AGENT | 2023-01-05 | — | — | US | disclosed |
| EP-4112660-A1 | PROCESSING OPTIMIZED REACTIVE POLYMER COMPOSITION | Clariant International Ltd (CH) | 2023-01-04 | — | — | EP | disclosed |
| EP-3781622-B1 | ADHESIVE COMPOSITIONS WITH A GELCONTENT FROM CROSSLINKING OF KETO- OR ALDEHYDE GROUPS | BASF SE (DE) | 2022-10-12 | — | — | EP | disclosed |
| EP-4031527-A1 | HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ModernaTX, Inc. (US) | 2022-07-27 | — | — | EP | disclosed |
| WO-2021055849-A1 | HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| WO-2021055849-A1 | HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| EP-0282077-B1 | Pyridyloxy derivatives | FUJIREBIO KK (JP) | 1993-11-10 | — | — | EP | disclosed |
| US-4988828-A | Antiulcer agents, antagonist for histamine H2 receptors | FUJIREBIO KABUSHIKI KAISHA (JP) | 1991-01-29 | — | — | US | disclosed |
| US-4977267-A | ANTISECRETORY AGENT | FUJIREBIO KABUSHIKI KAISHA (JP) | 1990-12-11 | — | — | US | disclosed |
| US-4912101-A | Containing a secondary amide, suflur group and a furan ring | FUJIREBIO KABUSHIKI KAISHA (JP) | 1990-03-27 | — | — | US | disclosed |
| US-4837316-A | ANTIULCER AGENTS | FUJIREBIO KABUSHIKI KAISHA (JP) | 1989-06-06 | — | — | US | disclosed |
| EP-0318036-A2 | Phenoxypropyl derivatives | FUJIREBIO KABUSHIKI KAISHA (JP) | 1989-05-31 | — | — | EP | disclosed |
| EP-0282077-A2 | Pyridyloxy derivatives | FUJIREBIO KABUSHIKI KAISHA (JP) | 1988-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000773-A1 | NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | LNPK, PEBP1, PLTP | ALDH1A1 4749/4885TAS2R14 3435/4885ALOX5 3412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.